Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF)

CUSIP: G39342103

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+769,498
Put/Call ratio
49%
SEC-reported price per share
$2.96
Number of holders
24
Value change
+$188,969
Number of buys
13
Open additional details 1 more signal available
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
133,765,508

Security key

G39342103

Report period

Q2 2022

Institutions

24

Top holders

10

Ownership snapshot

Top reported holders of CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Oasis Management Co Ltd.
Disclosed value leader
Oasis Management Co Ltd.
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $13,587,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Oasis Management Co Ltd. has the largest disclosed position value at $13.59M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Oasis Management Co Ltd.'s linked filing trail.
Disclosed position value Top 5
Oasis Management Co Ltd. $13.59M
RENAISSANCE TECHNOLOGIES LLC $10.36M
Man Group plc $6.94M
BlueCrest Capital Management Ltd $5.59M
Qube Research & Technologies Ltd $1.73M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Oasis Management Co Ltd.
13F
Company
13F
—
denominator unverified
$13,587,000
3,529,141 shares
— 31 Mar 2022
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$10,356,000
2,689,974 shares
— 31 Mar 2022
Man Group plc
13F
Company
13F
—
denominator unverified
$6,935,000
1,801,336 shares
— 31 Mar 2022
BlueCrest Capital Management Ltd
13F
Company
13F
—
denominator unverified
$5,593,000
1,452,603 shares
— 31 Mar 2022
Qube Research & Technologies Ltd
13F
Company
13F
—
denominator unverified
$1,728,000
448,755 shares
— 31 Mar 2022
Quinn Opportunity Partners LLC
13F
Company
13F
—
denominator unverified
$1,249,000
324,494 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
24
Shares
11,720,823
Rows available
24
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q2 2022 holders
24
Holder diff
23
Investor Q1 2026 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2026 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .